Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now full pipeline small index

Chronic Migraine, Headache: full-pipeline trial registry

1 of 5 indexed Chronic Migraine, Headache trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Chronic Migraine, Headache: 5 US clinical trials tracked, 1 recruiting.

Chronic Migraine, Headache is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Chicago Headache Center & Research Institute, running 1 of these trials.

Enrollment posture brief

Registry condition chronic-migraine-headache

OPEN 1 | RECR 20% | LATE 1 | EARLY 1 | RANK #3391 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Chronic Migraine, Headac (th…20%
Open-enrollment share among volume-matched conditions near Chronic Migraine, Headache

Chronic Migraine, Headache lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Chronic Migraine, Headache on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Chronic Migraine, Headache is recruiting below its size-band peers.

    1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Chronic Migraine, Headache research.

    Chicago Headache Center & Research Institute accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Chronic Migraine, Headache enrolment sits around 110 participants.

    Median target enrolment is 110 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.

  4. Chronic Migraine, Headache splits between interventional and observational designs.

    3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 41

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 4 1

Named interventions

Most-linked intervention names on Chronic Migraine, Headache records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Occipital Nerve Stimulation Device
1 trials
Combination of Botox + CGRPmAb (Fremanezumab 225mg/1.5mL) Drug
1 trials
Nerivio REN device Device
1 trials
Daxibotulinumtonix A Biological
1 trials
CGRP antibody or gepant Drug
1 trials

US sites by state

Facility locations filed on Chronic Migraine, Headache trials. A trial with sites in several states counts in each.

California 2 trials
Pennsylvania 1 trials
Oklahoma 1 trials
New Jersey 1 trials
Michigan 1 trials
Illinois 1 trials
Florida 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Chronic Migraine, Headache page

5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Migraine, Headache condition card totals 5 registered trials; most-linked intervention Occipital Nerve Stimulation; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.